Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study

被引：0
|
作者：
Piero Barbanti
Cinzia Aurilia
Gabriella Egeo
Stefania Proietti
Florindo D’Onofrio
Paola Torelli
Marco Aguggia
Davide Bertuzzo
Cinzia Finocchi
Michele Trimboli
Sabina Cevoli
Giulia Fiorentini
Bianca Orlando
Maurizio Zucco
Laura Di Clemente
Ilaria Cetta
Bruno Colombo
Monica Laura Bandettini di Poggio
Valentina Favoni
Licia Grazzi
Antonio Salerno
Antonio Carnevale
Micaela Robotti
Fabio Frediani
Claudia Altamura
Massimo Filippi
Fabrizio Vernieri
Stefano Bonassi
机构：
[1] IRCCS San Raffaele Roma,Headache and Pain Unit
[2] San Raffaele University,Clinical and Molecular Epidemiology
[3] IRCCS San Raffaele Roma,Headache Center Neurology Unit
[4] San Giuseppe Moscati Hospital,Unit of Neurology, Department of Medicine and Surgery, Headache Center
[5] University of Parma,Headache Center
[6] Headache Center Cardinal Massaia,Neurology Unit, IRCCS San Raffaele Scientific Institute
[7] Divisione di Neurologia,Neuroalgology Unit, Headache Center Fondazione
[8] University Magna Graecia,Headache Center
[9] IRCCS Istituto delle Scienze Neurologiche di Bologna,Headache and Neurosonology Unit
[10] San Camillo-Forlanini Hospital,undefined
[11] Vita-Salute San Raffaele University,undefined
[12] IRCCS Ospedale Policlinico San Martino,undefined
[13] IRCCS Istituto Neurologico“Carlo Besta”,undefined
[14] Headache Center San Giovanni Addolorata Hospital,undefined
[15] Headache Center San Filippo Neri Hospital,undefined
[16] ASST Santi Paolo Carlo,undefined
[17] Policlinico Universitario Campus Bio-Medico,undefined
来源：
Journal of Neurology | 2024年 / 271卷
关键词：
Migraine; Treatment; Anti-CGRP mAbs; Responder; Late response; Ultra-late response; Real-life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2434 / 2443
页数：9
相关论文
共 50 条
  • [41] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
    Carlo Lovati
    Gianna Bernasconi
    Chiara Capogrosso
    Laura Molteni
    Federica Giorgetti
    Bernardo Dell’Osso
    Leonardo Pantoni
    Neurological Sciences, 2022, 43 : 5765 - 5767
  • [42] Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment
    Salim, Amira
    Najjar, Atia
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
  • [43] ANTI-CGRP MONOCLONAL ANTIBODIES FOR NEUROPATHIC PAIN IN PATIENTS WITH MIGRAINE HEADACHE
    Kang, Seung Ah
    Govindarajan, Raghav
    MUSCLE & NERVE, 2020, 62 : S7 - S7
  • [44] Anti-CGRP Monoclonal Antibodies for Neuropathic Pain in Patients with Migraine Headache
    Kang, Seung Ah
    Govindarajan, Raghav
    NEUROLOGY, 2021, 96 (15)
  • [45] Predictors of ≥50% and ≥75% response to anti-CGRP monoclonal antibodies for migraine prevention in real life: results from a european multicenter observational study including 5818 patients
    Caronna, E.
    Gallardo, V. J.
    Alpuente, A.
    Torres-Ferrus, M.
    Huerta Villanueva, M.
    Munoz-Vendrell, A.
    Campoy Diaz, S.
    Obach Baurier, V.
    Fabregat Fabra, N.
    Gago-Viega, A.
    Sanchez Soblechero, A.
    Lozano Ros, A.
    Diaz de Teran, J.
    Membrilla Lopez, J. A.
    Rodriguez-Vico, J. S.
    Guerrero Peral, A. L.
    Garcia Azorin, D.
    Pascual, J.
    Garate, G.
    Cuadrado Godia, E.
    Dorado, L.
    Sanahuja, J.
    Echeverria Urabayen, A.
    Irimia Sieira, P.
    Sanchez del Rio, M.
    Lopez-Bravo, A.
    Alvarez Escudero, R.
    Velasco Juanes, F.
    Santos Lasaosa, S.
    Diaz Insa, S.
    Layos-Romero, A.
    Andres Lopez, A.
    Viguera Romero, J.
    Beltran Blasco, I.
    Gonzalez Oria, C.
    Zapata, S.
    Flores Pina, B.
    Fernandez Lazaro, I.
    Quintas Gutierrez, S.
    Gonzalez Martinez, A.
    Jaimes Sanchez, A.
    Garcia Gomez, A.
    Gonzalez Osorio, Y.
    Gonzalez-Quintanilla, V.
    Kortazar Zubizarreta, I.
    Manera Zorrilla-Lequerica, P.
    Miro Munoz, I.
    Guisado-Alonso, D.
    Oterino Duran, A.
    Riesco Perez, N.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [46] RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine
    Gonzalez Martinez, A.
    Romero del Rincon, C.
    Quintas Gutierrez, S.
    Garcia Azorin, D.
    Fernandez Lazaro, I.
    Guerrero Peral, A. L.
    Gonzalez Osorio, Y.
    Iglesias Diez, F.
    Echavarria Iniguez, A.
    Gil Luque, S.
    Huerta Villanueva, M.
    Campoy Diaz, S.
    Munoz Vendrell, A.
    Velasco Juanes, F.
    Lozano Ros, A.
    Sanchez Soblechero, A.
    Morollon Sanchez-Mateos, N.
    Belvis, R.
    Kortazar Zubizarreta, I.
    Echeverria Urabayen, A.
    Rodrigue-Vico, J. S.
    Jaimes Sanchez, A.
    Gomez Garcia, A.
    Navarro Perez, M. P.
    Montes, N.
    Gago-Viega, A.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [47] Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants
    Do, T. P.
    Al-Saoudi, A.
    Ashina, M.
    REVUE NEUROLOGIQUE, 2021, 177 (07) : 827 - 833
  • [48] Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies
    Khodavirdi, Ani C.
    Multani, Jasjit K.
    Oh, Sam S.
    Vuvu, Fiston
    Bensink, Mark E.
    Stockl, Karen M.
    Hawkins, Kevin
    Chiang, Chia-Chun
    Green, A. Laine
    Tepper, Stewart J.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [49] Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies A Prospective Follow-up Study
    Lentsch, Simone de Vries
    van der Arend, Britt W. H.
    VandenBrink, Antoinette Maassen
    Terwindt, Gisela M.
    NEUROLOGY, 2022, 99 (17) : E1897 - E1904
  • [50] Placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
    Regnier, S.
    Lee, X. Ying
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
12345